PGV

New Findings in JNCCN Illustrate Pathway for Screening High-Risk Individuals for Pancreatic Cancer in PRECEDE Study

Retrieved on: 
星期二, 四月 16, 2024
University, Clinical trial, NCCN, Pancreas, McGill University Health Centre, Risk, Pancreatic cancer, Breast, Prevalence, Cancer, National Comprehensive Cancer Network, Rosalind, Survival, Survival rate, Cyst, Doctor of Philosophy, Huntsman Cancer Institute, Research, Moores Cancer Center, Consortium, Disease, Incidence, Patient, Pancreatic Cancer Action Network, Diagnosis, Research institute, PGV, Dana–Farber Cancer Institute, Morávek, UC, McGill University, Pharmaceutical industry

PLYMOUTH MEETING, Pa., April 16, 2024 /PRNewswire/ -- New research in the April 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer. Global incidences of pancreatic cancer have risen dramatically in recent years, but the overall survival rate is currently only 12%. When pancreatic neoplasms are detected early enough for treatment with surgical resection, the survival rate climbs to better than 80%, but unfortunately the vast majority of patients are diagnosed with advanced-stage disease. The Pancreatic Cancer Early Detection (PRECEDE) Consortium is a global effort to increase screening capacity for this disease. Of 1,759 participants sorted into the highest-risk cohort, nearly 80% completed baseline imaging through PRECEDE.

Key Points: 
  • Global incidences of pancreatic cancer have risen dramatically in recent years, but the overall survival rate is currently only 12%.
  • The Pancreatic Cancer Early Detection (PRECEDE) Consortium is a global effort to increase screening capacity for this disease.
  • "I look forward to further research... to improve access to pancreatic cancer screening for high-risk individuals."
  • "Longer follow-up time is needed to determine if familial pancreatic cancer signifies a higher risk for developing pancreatic cancer compared to pathogenic germline variant (PGV) status in a pancreatic cancer predisposition gene."

Ormat Technologies Reports Fourth Quarter and Year-End 2023 Financial Results

Retrieved on: 
星期三, 二月 21, 2024
Acquisition, PGV, Energy, Electricity, BESS, Growth, PPA, Energy storage, Adjustment, CAISO, PJM, Webcast, Policy, EPS, Public utility, Renewable energy

RENO, Nev., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (the “Company,” “Ormat,” “we” or “us”),  a leading renewable energy company, today announced financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • “I am pleased to report that Ormat delivered another quarter of solid results, marking a strong conclusion to a successful year in 2023,” said Doron Blachar, Chief Executive Officer of Ormat.
  • Diluted EPS for the fourth quarter and for the year 2023 were $0.59 and $2.08 per share, respectively, an increase of 84.4% and 77.8%, respectively, compared to last year.
  • Adjusted EBITDA for the fourth quarter and for the year 2023 were $139.0 million, and $481.7 million, respectively, an increase of 11.5% and 10.6%, respectively, compared to 2022.
  • The Company provides a reconciliation of Adjusted EBITDA, a non-GAAP financial measure for the quarter and year ended December 31, 2023.

Ormat Secures Approval for PPA Amendments Between Its Puna Geothermal Venture and Hawaiian Electric

Retrieved on: 
星期一, 二月 12, 2024
EIS, PGV, Electricity, PPA, RENO, Environmental issues, Partnership, Renewable energy

RENO, Nev., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA), a leading renewable energy company, announces Hawai’i Public Utilities Commission’s (HPUC) approval of two final amendments to the Power Purchase Agreement (PPA) between its subsidiary, Puna Geothermal Venture (PGV), and Hawaiian Electric. This landmark decision enables PGV to contribute up to an additional 8 megawatts (MW) of clean, dispatchable renewable power to Hawai’i Island, elevating the contract maximum capacity to 46 MW, with a minimum contracted capacity set at 30 MW. The approval follows PGV’s completion and submission of its final Environmental Impact Statement (EIS) for operations in Puna, Hawai’i. The EIS was a condition set by the HPUC for approval of an amended and restated PPA that was submitted to the HPUC in December 2019.

Key Points: 
  • Amended and restated PPA secures fixed energy rate, PPA extension and project expansion
    RENO, Nev., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA), a leading renewable energy company, announces Hawai’i Public Utilities Commission’s (HPUC) approval of two final amendments to the Power Purchase Agreement (PPA) between its subsidiary, Puna Geothermal Venture (PGV), and Hawaiian Electric.
  • The approval follows PGV’s completion and submission of its final Environmental Impact Statement (EIS) for operations in Puna, Hawai’i.
  • The EIS was a condition set by the HPUC for approval of an amended and restated PPA that was submitted to the HPUC in December 2019.
  • Doron Blachar, CEO of Ormat Technologies said, “Ormat is pleased to extend and expand our partnership with Hawaiian Electric and continue demonstrating our ability to support the state’s energy needs.

Cadence AI-Based Virtuoso Studio Certified for Samsung Foundry PDKs for Mature and Advanced Nodes

Retrieved on: 
星期二, 六月 27, 2023
Software, Networks, Internet, Data Management, Technology, Apps, Applications, Mobile, Wireless, Security, DFM, Custom, DRC, Kurdistan, Cadence Design Systems, Samsung Electronics, LVS, CDNS, Pegasus, Adobe InDesign, SF2, Samsung, Head, ICS, SF3, SOC, Certification, Self Control (Raf song), HMF, Hyperscale computing, PGV, Studio, AI, RF, Mobile phone, Cadence

Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced that the AI-based Cadence® Virtuoso® Studio design tools and solutions have been certified by Samsung Foundry.

Key Points: 
  • Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced that the AI-based Cadence® Virtuoso® Studio design tools and solutions have been certified by Samsung Foundry.
  • Joint customers can confidently leverage Virtuoso Studio and Samsung’s mature and advanced node process design kits (PDKs) down to SF2 to advance next-generation analog, custom, RF and mixed-signal design.
  • The Cadence Voltus™-XFi Custom Power Integrity Solution, also integrated with Virtuoso Studio, is also now optimized and certified for Samsung Foundry’s advanced process technologies.
  • This enables customers to confidently adopt state-of-the-art and future-ready custom IC design flow with Samsung Foundry PDKs.

New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology

Retrieved on: 
星期五, 五月 26, 2023
University of Vermont Medical Center, Pancreatic cancer, Male, University, Stanford University, Registry, GGT, Lung cancer, Genetic testing, Research, Prostate, ASCO, VCU, Genetic counseling, PGV, American Society of Clinical Oncology, Patient, Laboratory, VCU Massey Cancer Center, Colorectal cancer, SAN, Virginia Commonwealth University, Annual general meeting, SEER, CDT, Ovarian cancer, Society, NYSE, Disease, Breast cancer, Prostate cancer, Pharmaceutical industry, Medical device, Vaccine, Medical imaging, Invitae

SAN FRANCISCO, May 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine studies to be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from June 2-6, 2023. The new research insights highlight innovations in genetic testing in a variety of clinical settings, population groups and cancer types, and reinforce the need to reduce barriers to genetic services to help patients receive the most effective care and monitoring. 

Key Points: 
  • "Significant gaps persist in the uptake of germline genetic testing across cancer types," stated W. Michael Korn, M.D., chief medical officer for oncology at Invitae.
  • Poster 240/Abstract 10607: Titled: Using patient-reported outcomes to assess the impact of germline genetic testing on prostate cancer patients.
  • Poster 183/Abstract 10550: Titled: Disparities in Germline Genetic Testing Results from a Cohort of ~493,515 Black and White Patients.
  • Poster 250/Abstract 10617: Titled: Eliminating barriers to uptake of germline genetic testing for patients with advanced cancer: the GTAC study.

Telos Corporation Accelerates Growth at Major U.S. Airports

Retrieved on: 
星期一, 八月 23, 2021
Diamond, Telos (company), Industry, Company, Result, BUR, Transportation Security Administration, MDW, DAC, Analysis, U.S. Securities and Exchange Commission, MSF, Nature, GLOBE, SEC, Federation, Hollywood Burbank Airport, PGV, TLS, Friction, TSA, Intelligence, Transport, Risk management, NASDAQ, News, PIE, Compliance, Solution, Credentialing, Financial condition report, PBG, SMF, ALB, ORD, Aviation, United States Department of Homeland Security, DHS, Annual report, Department, Technology, Pitt–Greenville Airport, Airline

Pitt-Greenville Airport (PGV) and Airbahn, Telos newest DAC customers, join an impressive roster of aviation customers, including those renewing Telos DAC services, such as Chicago OHare Intl.

Key Points: 
  • Pitt-Greenville Airport (PGV) and Airbahn, Telos newest DAC customers, join an impressive roster of aviation customers, including those renewing Telos DAC services, such as Chicago OHare Intl.
  • Telos services meet Transportation Security Administration (TSA) and Department of Homeland Security (DHS) requirements for handling personally identifiable information and biometrics.
  • This news follows the recent announcement that Telos acquired the assets and patents of Diamond Fortress Technologies to integrate the ONYX touchless fingerprinting technology with Telos IDTrust360 platform.
  • Telos Corporation (NASDAQ: TLS) empowers and protects the worlds most security-conscious organizations with solutions for continuous security assurance of individuals, systems, and information.

Ormat’s Puna Geothermal Venture and Hawaiian Electric Announce Amended Power Purchase Agreement

Retrieved on: 
星期一, 一月 6, 2020
Energy, Energy in Hawaii, Geothermal energy, Geothermal energy in the United States, Kilauea, Puna Geothermal Venture, Alternative energy, Ormat Technologies, PGV, Geothermal power, Nature

RENO, Nev., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc.1 (NYSE: ORA) today announced that its subsidiary, Puna Geothermal Venture (PGV), and Hawaiian Electrics Hawaii Electric Light subsidiary have reached an agreement on an amended and restated power purchase agreement (PPA) for dispatchable geothermal power sold from Ormats Puna complex, located on the Big Island of Hawaii.

Key Points: 
  • RENO, Nev., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc.1 (NYSE: ORA) today announced that its subsidiary, Puna Geothermal Venture (PGV), and Hawaiian Electrics Hawaii Electric Light subsidiary have reached an agreement on an amended and restated power purchase agreement (PPA) for dispatchable geothermal power sold from Ormats Puna complex, located on the Big Island of Hawaii.
  • This upgraded facility will utilize the same amount of geothermal resource that the existing 38 MW facility requires.
  • Ormats reconstruction efforts to bring the 38MW complex back to operation are underway, and we continue our geothermal field recovery work.
  • Ormats flexible, modular solutions for geothermal power and REG are ideal for vast range of resource characteristics.